SMAD3 and triple-negative breast carcinoma: Then, TRIM24-SMAD3 complex is recruited to chromatin, which enhances SMAD3 activation and immune response-related cytokine expression, ultimately promotes breast cancer stemness and enhances metastasis in triple-negative breast cancer.